UNVEILING THE THERAPEUTIC POTENTIAL OF CORIANDRUM SATIVUM LEAVES: ANTIDIABETIC, ANTIPYRETIC, AND ANTIMICROBIAL INSIGHTS

Main Article Content

Mohit Kotnala
Kanupriya Sharma

Keywords

.

Abstract

The present study was designed to investigate and establish the folklore uses of Coriandrum sativum (Linn) as antidiabetic, antipyretic and antimicrobial agent. The antidiabetic activity of methanolic extract of Coriandrum sativum was studied in alloxan induced diabetic rats at the doses of 200 and 400mg/kg body weight for the period of 21 days and its effect on blood– glucose, serum insulin and lipid profile was estimated during the study.


Paracetamol (150mg/kg body weight by oral) was used as reference drug and control group received 2% Tween 80. Rectal temperatures of all rats were recorded and compared at 19h immediately before extract or paracetamol or vehicle administration and again at 1 h interval up to 23 h. The CSLE ( 200 and 400mg/kg by oral ) showed significant and dose dependent reduction in pyrexia. The extract had shown a significant dose dependent antipyreic effect comparable with standard drug paracetamol.


The extract was found to possess a significant antibacterial effect against Gram -ve (E.coli, Shigella spp, Vibrio spp) appeared to be most susceptible to CSLE than the gram positive  (Bacillus spp, S. aureus) organisms. The minimum inhibitory concentration (m.i.c) and zone of inhibition (in mm) was determined by checker board technique and disc diffusion technique respectively.


The extract was found to possess a significant antifungal effect against various strains of Candida. It was found that Candida albicans ATCC-10231 and Candida albicans 5 were completely inhibited at 200 µg/ml. Inhibition of growth of Penicillin notatum started at 100 µg/ml and was completely inhibited at 400 µg/ml.

Abstract 86 | PDF Downloads 31

References

A. REFERENCES FROM RESEARCH PAPER
1. Bennett, W. L., Maruthur, N. M., Singh, S., Segal, J. B., Wilson, L. M. Chatterjee, R., Marinopoulos, S. S, Puhan., 2011) Comparative effectiveness and safety of medications for type diabetes: An update including new drugs and 2-drug combinations".Annals of internal medicine 154 (9), pp. 602–613. PMID 21403054.
2. Essawi, T., Srour, M., 2000, Screening of some Palestinian medicinal plants for antibacterial activity., Journal of Ethanopharmacology, Vol. 70, pp. 343-349.
3. Farnsworth, NR., Morris, RW.,1976. Higher plants--the sleeping giant of drug development. American journal of pharmacy. 148: 46-52
4. Grant, RW., Moore, AF., and Florez, JC.,2009, Genetic architecture of type 2 diabetes: Diabetes Care. 32(6), pp. 1107–1114.
5. Gallwitz., 2006, Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study data. International journal of clinical practice. Pp. 1654-61.
6. Johnson., 2002, The concept of sickness behavior: a brief chronological account of four key discoveries. Veterinary immunology and immunopathology 443–50. PMID 12072271
7. Kristova, V., Liskoya, S., Sotnikova, S., Vojtko, R., Kurtansky, A., 2008, Sulodexide improves Endothelial Dysfunction on Streptozotocin- Induced Diabetic Rats. International Journal of Pharmaceutical Sciences. pp. 491-494.
8. Kgmm, Alberti,. and Zimmet., 1998,WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Diabetic Medicine, 15: pp. 539-553.
9. Kelley, KW., Bluthe, RM., Dantzer, R., Zhou, JH., Shen, WH., Johnson, RW., Broussard, SR., 2003, Cytokine-induced sickness behavior. Brain, behavior, and immunity. 17 Suppl 1: S112–8. PMID 12615196
10. Lowy, Df., 2003, Antimicrobial resistance: The ex of Staphylococcus aureus, J. Clin.invest. pp. 1265-1273.
11. Mathew, AG., Cissell, R., Liamthong, S., 2007 Antibiotic resistance in bacteria associated with food animals: a United States perspective of livestock production Foodborne Pathog. Dis. 4 (2): 115–33.
12. 60. Stefferl, Andreas, Stephen, J., Hopkins, Nancy J., Rothwell & Giamal N. Luheshi , 1996. The role of TNF-a in fever: opposing actions of human and murine TNF-oa and interactions with IL-fl in the rat. Brftish Journal of Pharmacology.pp. 12-27.
13. Shah, B.N., Seth, A.K., 2010, Medicinal Plants as a source of Anti-Pyretic Agents- A Review, Archives of Applied Science Research , Vol. 2, Issue 3, pp. 188-195.
14. Trivedi, NA., Majumder, B., Bhalt, JD., Hermavathi, KG., 2004, Effect of shilajat on blood glucose and lipid profile in alloxan –induced diabetic rats. Indian journal pharmacol, pp.373- 376.
15. Verma, Sheetal., and singh, sp., 2011,Current and Future status of herbal medicines,veterinary world. Vol 1, Issue 11.pp, 347-350.
16. Woodford, N., 2003, Novel agents for the treatment of resistant Gram positive infections. Expert Opinion on investigating Drugs , Vol. 12, pp 347-350.

B. REFERENCES FROM BOOK
17. David, G. Gardner., 2011,Greenspan's basic & clinical endocrinology. NewYork, McGraw-Hill Medical,chapter 17, pp. 162242-48.
18. Mukherjee, Pulok K., and Houngton., j Peter., 2009. Evaluation of Herbal Medicinal Products, RPS Publication, Great Britain, pp,20.
19. Mukherjee, Pulok K., Sahu, M, Suresh B., 1998, Indian Herbal Medicines , The Estern Pharmacist, vol-8, Issue 42, pp 21-24.
20. Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson.,2001, Robbins Basic Pathology. Philadelphia: Saunders. ISBN 1-4160-2973-7. 8th edition.
21. Tiwari, D.N., 2000, Report of the Task force on Conservation and Sustainable use of Medicinal plant, Govt of India planning Commission.
22. Waugh, A., Grant, A., 2003.Ross and Wilson Anatomy and Physiology in Health and Illness. Churchill Livingstone, Spain.
C. REFERNCES FROM URL ( SITE)
23. Todar, K., 2008 University of Wisconsin ( online), Available at: http:// www. Text book of bacteriology. Net/ken todar.html, ( assessed 17 April, 2012).